Stock Traders Purchase High Volume of Put Options on Pediatrix Medical Group (NYSE:MD)

Posted by Brenda Bartman on Jul 17th, 2026

Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock traders acquired 6,020 put options on the company. This represents an increase of approximately 1,686% compared to the average volume of 337 put options.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on MD. Jefferies Financial Group reaffirmed a “buy” rating and issued a $27.00 price target on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Mizuho set a $24.00 target price on Pediatrix Medical Group in a research report on Friday, May 8th. Truist Financial increased their price target on Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a report on Tuesday. UBS Group lifted their price target on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $23.33.

Read Our Latest Stock Report on Pediatrix Medical Group

Pediatrix Medical Group Price Performance

Shares of MD stock opened at $26.29 on Friday. The stock’s fifty day simple moving average is $23.86 and its 200 day simple moving average is $22.16. Pediatrix Medical Group has a one year low of $11.84 and a one year high of $27.94. The firm has a market cap of $2.16 billion, a price-to-earnings ratio of 12.76 and a beta of 0.66. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.33 and a quick ratio of 1.33.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.37 by $0.07. The company had revenue of $476.20 million for the quarter, compared to the consensus estimate of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.33 EPS. On average, analysts expect that Pediatrix Medical Group will post 2.1 earnings per share for the current fiscal year.

Insider Buying and Selling at Pediatrix Medical Group

In related news, Director Shirley A. Weis sold 36,028 shares of Pediatrix Medical Group stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of large investors have recently bought and sold shares of the business. Global Retirement Partners LLC increased its stake in shares of Pediatrix Medical Group by 68,250.0% in the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after buying an additional 1,365 shares in the last quarter. Transamerica Financial Advisors LLC acquired a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at approximately $30,000. Eurizon Capital SGR S.p.A. acquired a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at approximately $33,000. Blue Trust Inc. bought a new position in Pediatrix Medical Group in the 4th quarter worth approximately $37,000. Finally, TD Private Client Wealth LLC bought a new position in Pediatrix Medical Group in the 4th quarter worth approximately $39,000. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Company Profile

(Get Free Report)

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.